The IMMUNONET workshop "Public-Private Partnership in Immuno-Oncology was held on November 5, 2018 at COBIS A/S in Copenhagen. Photo: Mette Wassard Yde, IMMUNONET
08-11-2018
IMMUNONET hosted a Public-Private Partnership workshop on immune-oncology with 80 participants from all over Denmark.
The workshop included a keynote presentation by Martin Bonde, CEO of Vaccibody AS and former chair of the board at Dansk Biotek. He spoke about his own experiences with biotech spinoffs based on basic scientific discoveries by public institutions. The program also included eleven short presentations by different biotech companies and public research institutes working within the area and a small networking dinner to end the workshop.
What is IMMUNONET?
The purpose of IMMUNONET is to promote research in cancer immunotherapy by gathering clinical, translational and basic research in the area. IMMUNONET wishes to build a bridge between the immuno-oncological research environments at the universities, hospitals and in private companies.